Clinical Trial Update: A Proof-of-concept Trial for OPC 131461 in Patients Hospitalized for Worsening Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept trial of OPC-131461 for patients hospitalized with worsening heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• OPC-131461

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Heart Failure | Phase 2 | Status: WITHDRAWN